Clinical Trial Update: A Comparison of Rocuronium 0.6 mg/kg and Remifentanil 2 µg/kg in Elderly Patients Over 80 Years [Phase 4]

View source ↗

Summary

Phase 4 trial comparing rocuronium 0.6 mg/kg to remifentanil 2 µg/kg in elderly patients over 80 undergoing anesthesia, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia

Drugs mentioned

• Remifentanil (remifentanil)
• Rocuronium (rocuronium bromide)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Neuromuscular Blockade, Intubation Complication | Phase 4 | Status: COMPLETED